Midwestern University

Midwestern University, a private non-profit educational institution headquartered in Downers Grove, Illinois, serves the Department of the Navy and other federal agencies primarily as a recipient of tuition and educational services contracts, with a secondary footprint in health sciences research grants. The university operates as a prime recipient across 279 federal awards (98% of recent activity) and as a sub-recipient on seven grant awards, competing under full-and-open procurement with no set-aside designations.

The university's federal footprint is heavily concentrated in Navy tuition support. The Department of the Navy Bureau of Medicine and Surgery accounts for 129 awards (45% of all federal awards) with $11.7 million in combined potential value, anchored by two standing Basic Ordering Agreements—N0018910GZ017 (60 task orders, $5.6 million combined potential value) and N0018920GZ013 (53 task orders, $5.8 million combined potential value)—running through May 2030 and issuing delivery orders for tuition and fees spanning summer, fall, spring, and winter terms. Midwestern University holds a long-standing partner role providing medical education and training services to Navy and Marine Corps personnel through graduate and professional programs in medicine, pharmacy, and veterinary sciences. Representative contracts include a $118.1 thousand delivery order (April 13, 2026) and a $151.1 thousand delivery order (March 4, 2025) from the Navy for spring term tuition. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 places 20 awards ($1.5 million combined potential value), and the Department of the Navy (beyond the Bureau of Medicine and Surgery) issued 20 additional awards ($908 thousand combined potential value). The top five customer agencies by award count account for 67% of recent awards and 85% of combined potential value.

Beyond tuition contracting, Midwestern University receives federal research grant funding in health sciences and biomedical research. Recent NIH-funded recipients include a $1.76 million National Institute of Neurological Disorders and Stroke grant (August 1, 2025 through July 31, 2029) investigating microRNA as a therapeutic target for sickle cell disease pain management, with the University of Illinois serving as a sub-awardee; a $710.8 thousand National Institute of Diabetes and Digestive and Kidney Diseases grant (April 1, 2026 through January 31, 2030) on intrinsic primary afferent neurons in intestinal nutrient sensing and obesity, with Vanderbilt University Medical Center and Michigan State University as sub-recipients; a $554.3 thousand National Institute of Dental and Craniofacial Research grant (August 1, 2026 through July 31, 2028) establishing Xenopus laevis tadpole tail regeneration as an in vivo model for photobiomodulation therapy in oral mucositis; and a $296.2 thousand National Institute of Allergy and Infectious Diseases grant (June 24, 2026 through May 31, 2028) developing strategies to reduce drug-induced kidney injury from vancomycin, with the Children's Hospital of Philadelphia Research Institute as a sub-recipient. A $399.9 thousand Food and Drug Administration definitive contract (September 14, 2022 through September 29, 2025) addressed development and validation of continuous renal replacement therapy-specific beta-lactam population pharmacokinetic models, with Northwestern University's Sponsored Research Division serving as a subcontractor. The university also serves in a sub-recipient role on multiple grant initiatives led by Duke University, the Children's Hospital of Philadelphia, Northwestern University, and Children's Hospital Medical Center, contributing pharmacometrics and clinical infectious disease expertise.

Activity has declined modestly over the past five years—from 15 awards in 2022 to 9 awards in 2026 (as of August). Six awards reach ultimate completion within the next twenty-four months, representing limited recompete exposure in that window given the standing BOAs with the Navy Bureau of Medicine and Surgery. The university's primary service line—tuition and educational services—centers on graduate and professional health sciences education serving Navy personnel; secondary research capability spans pharmaceutical sciences, infectious disease pharmacometrics, and biomedical research in pain management, metabolic disease, and tissue engineering. The university has held federal contracting registration since 2002 and maintains tax-exempt status. Place of performance for tuition and educational services is the Downers Grove, Illinois campus; research work is performed in Downers Grove with distributed sub-recipient participation across multiple academic medical centers.